Direkt zum Inhalt
Merck
  • Biphasic changes in fetal heart rate variability in preterm fetal sheep developing hypotension after acute on chronic lipopolysaccharide exposure.

Biphasic changes in fetal heart rate variability in preterm fetal sheep developing hypotension after acute on chronic lipopolysaccharide exposure.

American journal of physiology. Regulatory, integrative and comparative physiology (2014-06-20)
Christopher A Lear, Joanne O Davidson, Lindsea C Booth, Guido Wassink, Robert Galinsky, Paul P Drury, Mhoyra Fraser, Laura Bennet, Alistair J Gunn
ZUSAMMENFASSUNG

Perinatal exposure to infection is highly associated with adverse outcomes. Experimentally, acute, severe exposure to gram-negative bacterial lipopolysaccharide (LPS) is associated with increased fetal heart rate variability (FHRV). It is unknown whether FHRV is affected by subclinical infection with or without acute exacerbations. We therefore tested the hypothesis that FHRV would be associated with hypotension after acute on chronic exposure to LPS. Chronically instrumented fetal sheep at 0.7 gestation were exposed to a continuous low-dose LPS infusion (n = 12, 100 ng/kg over 24 h, followed by 250 ng·kg(-1)·24 h(-1) for a further 96 h) or the same volume of saline (n = 10). Boluses of either 1 μg LPS or saline were given at 48, 72, and 96 h. Low-dose infusion was not associated with hemodynamic or FHRV changes. The first LPS bolus was associated with tachycardia and suppression of nuchal electromyographic activity in all fetuses. Seven of twelve fetuses developed hypotension (a fall in mean arterial blood pressure ≥5 mmHg). FHRV was transiently increased only at the onset of hypotension, in association with increased cytokine induction and electroencephalogram suppression. FHRV then fell before the nadir of hypotension, with transient suppression of short-term FHRV. After the second LPS bolus, the hypotension group showed a biphasic pattern of a transient increase in FHRV followed by more prolonged suppression. These findings suggest that infection-related hypotension in the preterm fetus mediates the transient increase in FHRV and that repeated exposure to LPS leads to progressive loss of FHRV.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Methanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ethylacetat, ACS reagent, ≥99.5%
Sigma-Aldrich
Ethylacetat, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Methanol, HPLC Plus, ≥99.9%
Sigma-Aldrich
Ethylacetat, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
Methanol, Laboratory Reagent, ≥99.6%
Sigma-Aldrich
Methanol, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
Methanol, ACS spectrophotometric grade, ≥99.9%
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ethylacetat, suitable for HPLC, ≥99.8%
Sigma-Aldrich
Ethylacetat, anhydrous, 99.8%
Sigma-Aldrich
Methanol, Absolute - Acetone free
USP
Methylalkohol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Methanol, BioReagent, ≥99.93%
Supelco
Methanol, analytical standard
Supelco
Ethylacetat, analytical standard
Supelco
Methanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Supelco
Ethylacetat, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ethylacetat, ≥99%, FCC, FG
Sigma-Aldrich
Ethylacetat, ACS reagent, ≥99.5%
Sigma-Aldrich
Ethylacetat
Sigma-Aldrich
Ethylacetat, natural, ≥99%, FCC, FG
Sigma-Aldrich
Ethylacetat, biotech. grade, ≥99.8%
Sigma-Aldrich
Ethylacetat, ReagentPlus®, ≥99.8%
Sigma-Aldrich
Methanol, suitable for NMR (reference standard)
Sigma-Aldrich
Methanol -Lösung, suitable for NMR (reference standard), 4% in methanol-d4 (99.8 atom % D), NMR tube size 3 mm × 8 in.